Dear all, There's no Sci Doscpurse call today: we are planning one next week with an update on the use cases.
Anita de Waard Disruptive Technologies Director Elsevier Labs http://elsatglabs.com/labs/anita On Oct 30, 2011, at 11:02 AM, "Waard, Anita de A (ELS-AMS)" <a.dewa...@elsevier.com> wrote: > Dear all, > > At our call tomorrow we will discuss the three use cases we are currently > working on: > > 1. Enhance Drug-mechanism Knowledge in Drug Product Labels > > * Leads: Richard Boyce, Jodi Schneider, Anita de Waard > * Partners: DERI, Elsevier – still need pharma partner > > 2. Defining minimal information requirements for biomedical investigations > defined and mapped to RDF > > * Leads: Tim Clark, Susanne Santone, David Shotton > > 3. Mining Treatment Outcomes: Develop a generic, anonymised, multi-EHS > compliant format and an information architecture that allows access to > symptom/treatment data as a Linked Data source that can be made freely > available and used for drug efficacy/outcome (meta)studies > > * Leads: Joanne Luciano, Anita de Waard > * Partners: RPI, Elsevier, - need clinical/patient forum and/or pharma > partner > > Dailin details and links to documents can be found at > http://www.w3.org/wiki/HCLSIG/SWANSIOC/Actions/RhetoricalStructure/meetings/20111031 > > Please update the webpage with the latest use case descriptions; we will be > submitting these to the HCLS as a whole shortly after the meeting. > > N.B.: Europe has gone to Daylight Savings Time but the US has not, so the > meeting will be at 10 am EST/3 pm CET! > > Best, > > - Anita. > > Anita de Waard > Disruptive Technologies Director, Elsevier Labs > http://elsatglabs.com/labs/anita/ > a.dewa...@elsevier.com > > > > -----Original Message----- > From: Waard, Anita de A (ELS-AMS) > Sent: Mon 10/24/2011 10:05 > To: Waard, Anita de A (ELS-AMS); Tim Clark; HCLS IG; > scidiscou...@googlegroups.com > Cc: Alberto Accomazzi; Allen, Bradley P (ELS-SDG); Sophia Ananiadou; Philip > Bourne; Gully Burns; Daniel, Ronald (ELS-SDG); Rahul Dave; Alf Eaton; > Alexander Garcia Castro; Matthew Gamble; Yolanda Gil; Alyssa Goodman; Paul > Groth; Tudor Groza; Hays, Ellen (ELS-BUR); Maryann Martone; David R Newman; > Scerri, Antony (ELS-CAM); Jack Park; Silvio Peroni; Steve Pettifer; Philippe > Rocca-Serra; Cartic Ramakrishnan; Jodi Schneider; David Shotton; Kaitlin > Thaney; Karin Verspoor; Lynette Hirschman; Susanna-Assunta Sansone; Kees van > Bochove; Katy Wolstencroft; Jun Zhao > Subject: No HCLS SciDiscourse call today - next call next week! > > Dear all, > > There's no SciDiscourse call this week since TIm, David Shotton and I are all > at a meeting in Boston - the next call is next week Monday when we will > discuss the status of the use cases. > > Current lineup of use cases: > 1) Product Insert Drug/Drug interaction (Jodi, Anita, Richard Boyce) > 2) Minimal information requirements for biomedical investigations (Tim, David) > 3) Mining Treatment Outcomes (JOanne, Anita) > > Others? > > Best, > > - Anita. > > Anita de Waard > Disruptive Technologies Director, Elsevier Labs > http://elsatglabs.com/labs/anita/ > a.dewa...@elsevier.com > > > > -----Original Message----- > From: Waard, Anita de A (ELS-AMS) > Sent: Sun 10/9/2011 19:28 > To: Waard, Anita de A (ELS-AMS); Tim Clark; HCLS IG; > scidiscou...@googlegroups.com > Cc: Alberto Accomazzi; Allen, Bradley P (ELS-SDG); Sophia Ananiadou; Philip > Bourne; Gully Burns; Daniel, Ronald (ELS-SDG); Rahul Dave; Alf Eaton; > Alexander Garcia Castro; Matthew Gamble; Yolanda Gil; Alyssa Goodman; Paul > Groth; Tudor Groza; Hays, Ellen (ELS-BUR); Maryann Martone; David R Newman; > Scerri, Antony (ELS-CAM); Jack Park; Silvio Peroni; Steve Pettifer; Philippe > Rocca-Serra; Cartic Ramakrishnan; Jodi Schneider; David Shotton; Kaitlin > Thaney; Karin Verspoor; Lynette Hirschman; Susanna-Assunta Sansone; Kees van > Bochove; Katy Wolstencroft; Jun Zhao > Subject: HCLS Scientific Discourse conference call - Use Case Review- Mon > October 10, 10am-11am EDT / 14:00-15:00 UTC > > Dear all, > > Tomorrow is the next Scientific Discourse Meeting. We will discuss the use > cases we are currently working on. Richard Boyce is joining our group and > will expand on his use case pertaining to drug package inserts. > > All use cases, to the extent that they are available, and the agenda and > dialup details can be found on our wiki: > http://www.w3.org/wiki/HCLSIG/SWANSIOC/Actions/RhetoricalStructure/meetings/20111010. > An unlinked version is given below. > > Best, > > Anita > > Anita de Waard > Disruptive Technologies Director, Elsevier Labs > http://elsatglabs.com/labs/anita/ > a.dewa...@elsevier.com > > Agenda: > > 1. Discuss tentative Use Cases > 2. Next steps > 3. AOB > > > [edit] Tentative use cases as per 06 Oct 2011 > > 1. Enhance Drug-mechanism Knowledge in Drug Product Labels > > * Lead: Richard Boyce > * Partners - possibly merge with next use case? > > 2. Annotating Truth Values: Helping Knowledge Discovery Through > Hypothesis-Based Epistemic Markup > > * Leads: Jodi Schneider, Anita de Waard > * Partners: DERI, Elsevier – still need pharma partner > > 3. MIBBI Core: defining minimal information requirements for biomedical > investigations defined and mapped to RDF > > * Leads: David Shotton, Tim Clark, Philippe Rocca-Serra > > 4. Structuring computer science publications during authoring - rewrite of > this use case > > * Leads: Tim Clark, Tudor Groza > * Partners: MGH/Harvard, Macquarie, Elsevier > > 5. Mining Treatment Outcomes: Develop a generic, anonymised, multi-EHS > compliant format and an information architecture that allows access to > symptom/treatment data as a Linked Data source that can be made freely > available and used for drug efficacy/outcome (meta)studies > > * Leads: Anita de Waard, Joanne Luciano > * Partners: RPI, Elsevier, - need clinical/patient forum and/or pharma > partner > > 6. Linking patient data to clinical recommendations, and recommendations to > clinical evidence > > * Leads: Paul Groth, Anita de Waard > * Partners: VU, Philips, Elsevier > > [edit] Dial-in & IRC Information: > > * Time: 10:00 EDT > * Dial-In #: +1.617.761.6200 (Cambridge, MA) > * Dial-In #: +33.4.26.46.79.03 (Paris, France) > * Dial-In #: +44.203.318.0479 (London, UK) > * Participant Access Code: 42572 ("HCLS2") > * IRC Channel: irc.w3.org port 6665 channel #HCLS2 use IRC direct link or > (see W3C IRC page for details, or see Web IRC) > * Mibbit quick start: Click on mibbit for instant IRC access > * Duration: 1hr > > -----Original Message----- > From: Waard, Anita de A (ELS-AMS) > Sent: Mon 9/26/2011 9:15 > To: Tim Clark; HCLS IG; scidiscou...@googlegroups.com > Cc: Alberto Accomazzi; Allen, Bradley P (ELS-SDG); Sophia Ananiadou; Philip > Bourne; Gully Burns; Daniel, Ronald (ELS-SDG); Rahul Dave; Alf Eaton; > Alexander Garcia Castro; Matthew Gamble; Yolanda Gil; Alyssa Goodman; Paul > Groth; Tudor Groza; Hays, Ellen (ELS-BUR); Maryann Martone; David R Newman; > Scerri, Antony (ELS-CAM); Jack Park; Silvio Peroni; Steve Pettifer; Philippe > Rocca-Serra; Cartic Ramakrishnan; Jodi Schneider; David Shotton; Kaitlin > Thaney; Karin Verspoor; Lynette Hirschman; Susanna-Assunta Sansone; Kees van > Bochove; Katy Wolstencroft; Jun Zhao > Subject: RE: Reminder: HCLS Sci Disc call - ISA-RDF & Use Case Review- Mon 26 > Sept 10am-11am EDT / 14:00-15:00 UTC > > Dear all, > > Further to the first agenda point, use cases, for our call in 42 minutes, I'd > like to review: > > a) The new HCLS Use Case template which can be found here: > https://docs.google.com/document/d/1DRnwXw7xIOLTjZ4TUiDtT80ouSQYfUqM9KWKXVgr60s/edit?hl=en_US > > b) Our current three use cases: > http://www.w3.org/wiki/HCLSIG/SWANSIOC/Actions/RhetoricalStructure#Use_Cases > > and ask ourselves and each other: > > 1) Are these use cases still valid, or have they been addressed by our work > so far? > 2) If they are valid, how can we get them to be compliant with the new > format: can someone take on each use cases? > 3) If there's time: brainstorm about other use cases, or otherwise make a > plan to gather more use cases before the next meeting. > > Talk in a bit! Best, > > - Anita. > > Anita de Waard > Disruptive Technologies Director, Elsevier Labs > http://elsatglabs.com/labs/anita/ > a.dewa...@elsevier.com > > > > -----Original Message----- > From: Tim Clark [mailto:tim.cl...@rcn.com] > Sent: Fri 9/23/2011 11:04 > To: HCLS IG; scidiscou...@googlegroups.com > Cc: Alberto Accomazzi; Allen, Bradley P (ELS-SDG); Sophia Ananiadou; Philip > Bourne; Gully Burns; Daniel, Ronald (ELS-SDG); Rahul Dave; Waard, Anita de A > (ELS-AMS); Alf Eaton; Alexander Garcia Castro; Matthew Gamble; Yolanda Gil; > Alyssa Goodman; Paul Groth; Tudor Groza; Hays, Ellen (ELS-BUR); Maryann > Martone; David R Newman; Scerri, Antony (ELS-CAM); Jack Park; Silvio Peroni; > Steve Pettifer; Philippe Rocca-Serra; Cartic Ramakrishnan; Jodi Schneider; > David Shotton; Kaitlin Thaney; Karin Verspoor; Lynette Hirschman; > Susanna-Assunta Sansone; Kees van Bochove; Katy Wolstencroft; Jun Zhao > Subject: Reminder: HCLS Sci Disc call - ISA-RDF & Use Case Review- Mon 26 > Sept 10am-11am EDT / 14:00-15:00 UTC > > Colleagues: > > This is a reminder for the biweekly HCLS Scientific Discourse concall > scheduled for Monday, 26 Sept 10am-11am EDT / 14:00-15:00 UTC. > > As discussed in the previous call, we'll be focusing on defined tasks and use > cases for the coming year. > > - we will begin a review and update of our use cases > > - ISA-RDF will be discussed as a potential shared task for 2011-12 (see > underlying ISA-TAB project here: http://isa-tools.org/ for some background) > Dial-in & IRC Information > > Dial-In #: +1.617.761.6200 (Cambridge, MA) > Dial-In #: +33.4.26.46.79.03 (Paris, France) > Dial-In #: +44.203.318.0479 (London, UK) > Participant Access Code: 42572 ("HCLS2") > IRC Channel: irc.w3.org port 6665 channel #HCLS2 use IRC direct link or (see > W3C IRC page for details, or see Web IRC) > Mibbit quick start: Click on mibbit for instant IRC access > Duration: 1hr > Best > > Tim > > > > > > > > Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands, Registration No. 33156677 (The Netherlands)
